Insider Selling: 111 (NASDAQ:YI) Director Sells 70,440 Shares of Stock

111, Inc. Sponsored ADR (NASDAQ:YI – Get Free Report) Director Jun Justin Luo sold 70,440 shares of the company’s stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $0.25, for a total transaction of $17,610.00. Following the completion of the sale, the director owned 710,551 shares of the company’s stock, valued at approximately $177,637.75. This trade represents a 9.02% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jun Justin Luo also recently made the following trade(s):

Get 111 alerts:

• On Tuesday, May 26th, Jun Justin Luo sold 29,280 shares of 111 stock. The shares were sold at an average price of $0.27, for a total transaction of $7,905.60.

111 Stock Performance

Shares of NASDAQ:YI opened at $5.47 on Friday. The company has a market cap of $48.08 million, a PE ratio of -5.47 and a beta of 0.66. 111, Inc. Sponsored ADR has a 52 week low of $2.48 and a 52 week high of $11.17. The firm has a 50 day simple moving average of $6.29 and a 200 day simple moving average of $5.58.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of 111 from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, May 21st. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.

View Our Latest Analysis on YI

About 111

(Get Free Report)

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.

Featured Articles

• Five stocks we like better than 111
• Flight Path to Profits: American Airlines Bets on SpaceX
• Wall Street Is Starting to Talk About Tesla’s Endgame
• Meta’s Manus Mess: Why China Blocked the Deal and What It Means
• China Deal Ignites Boeing’s Financial Afterburners

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.